References
- Clark B. J., Menninger K., Bertholet A. Pindolol - the pharmacology of a partial agonist. Br J Clin Pharmac. 1982; 13: 149S
- Curet LB., Olson R. W. Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy. Obst Gynaecol. 1979; 53: 336
- Department of Health and Social Security. Report on confidential inquiries into maternal deaths in England and Wales 1973-1975. HMSO, LondonEngland 1979; 21
- Dubois D., Petitcolas J., Temperville B., Klepper A. Catherine. P.H. Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists. Br J Clin Pharma. 1982; 13: 375S
- Ellenbogen A., Davidson A. Metabolic effects of pindolol on both mother and fetus. Curr Ther Res. 1988; 6: 1038
- Friedman E. A., Neff R. K. Hypertension-hypotension in pregnancy. JAMA 1978; 239: 2249
- Hogstedt S., Lindeberg S., Axelsson O., Lindmark G., Rane A., Sandstrom B. S. A prospective controlled trial of metoprololhydralazine treatment in hypertension during pregnancy. Acta Obstet Gynaecol Scand. 1985; 64: 505
- Ingemarsson J., Liedholm H., Montan S., Westgren M., Melander A. Fetal heart rate during treatment of maternal hypertension with beta adrenergic antagonists. Acta Obstet Gynaecol Scand. 1984; 118: 95S
- Leather H. M., Baker P., Humphreys D. M., et al. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet. 1963; 2: 488
- Lubbe W. F. Hypertension in pregnancy: whom and how to treat. Br J Clin Pharmacol. 1987; 24: 15S
- Lunell N. O., Nylund L., Lewander R., Sarby B., Wager J. J. Utero-placental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker pindolol. Gynaecol Obstet Invest 1984; 18: 269
- Plouin P. F., Breart G., Lllado J., et al. A randomised comparison of early with conservative use of antihypertensive drugs in management of pregnancy induced hypertension. Br J Obstet Gynaecol. 1990; 97: 134
- Pickles C. J., Symonds E. M., Broughton P. F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregancy-induced hypertension. Brit J Obstet Gynaecol. 1989; 96: 38
- Redman C. W. G., Beilin L. J., Bonnar J., Ounsted M. K. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976; 2: 753
- Redman C. W. G., Beilin L. J., Bonnar J. Treatment of hypertension in pregnancy with methyldopa: Blood pressure control and side effects. Brit J Obstet Gynaecol. 1977; 84: 419
- Redman C. W.G. The management of hypertension in pregnancy. Seminars in Nephrology 1984; 4: 270
- Rubin P. C., Clark D. M., Sumner D. J., et al. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet. 1983; 1: 431
- Sibai B. M., Abdella T. N., Anderson G. D. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet & Gynecology 1983; 61: 571
- Sibai B. M., Anderson G. D. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet & Gynecol. 1986; 67: 517
- Sibai B. M., Mabie W. C., Shamda F., Villar M. A., Anderson G. D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990; 162: 960
- Suckerman-Voldman E. Pindolol therapy in pregnant hypertensive patients. Br J Clin Pharma. 1982; 13: 379S